Federal Approval Granted to Stem Cell Research Method

The FDA’s approval of a trial of Mesenchymal Precursor Cells in the US for patients with hematological malignancies undergoing bone marrow transplants advances the prospects of stem therapy to treat common diseases. Scientists suggest that a transplantation hematopoietic stem and progenitor cells from the bone marrow of a healthy donor can save the lives of patients with damaged and destroyed bone marrow resulting from cancer treatments.

The FDA’s approval of a trial of Mesenchymal Precursor Cells in the US for patients with hematological malignancies undergoing bone marrow transplants advances the prospects of stem therapy to treat common diseases. Scientists suggest that a transplantation hematopoietic stem and progenitor cells from the bone marrow of a healthy donor can save the lives of patients with damaged and destroyed bone marrow resulting from cancer treatments.

View Full Story